Treating advanced prostate cancer demands more than clinical progress—it demands a new era of care, fueled by relentless innovation, collaborative efforts, and an unwavering push toward personalized treatment approaches.
Novartis is leading a transformation in prostate cancer care focused on improving outcomes—not just for the men and families touched by prostate cancer, but for the healthcare providers dedicating their lives to helping patients.
We can’t do it alone. Together with doctors, researchers, and professional groups, Novartis is accelerating this next era in prostate cancer care. Learn how we're making this a reality today and how to get involved.
1) We’re on the cutting edge of precision care
With advancements in precision medicine, men with advanced prostate cancer may have the potential to live longer and better. Precision care is personalized care—an approach that starts with listening to patient goals, then aligning treatment options to meet them. It’s a collaborative model where oncologists, urologists, nuclear medicine specialists, and others work together to deliver care that’s not just targeted, but truly centered on the individual.
There has long been a need for effective and differentiated treatment options that precisely target prostate cancer while minimizing the impact on patients’ day-to-day lives. That’s why we’re pushing the boundaries of medicine by developing technologies and platforms that deliver tangible outcomes for patients and providers across multiple treatment settings for advanced prostate cancer.
We believe precision technology has the potential to make this happen and are investing in collaborative solutions to bring it to life.
Discover the Novartis prostate cancer pipeline and clinical trials.
2) We’re transforming treatment with real-world data and collaboration
Our commitment to precision doesn't stop with our medicines. Together with leading urology and oncology experts, Novartis is proud to have built the aptly named PRECISION data platform (PRostatE Cancer dISease observatION data)—the largest real-world evidence source for advanced prostate cancer in the US.
Prostate cancer care is complex, not just for patients navigating the disease, but for both urologists and oncologists treating it. That’s where PRECISION brings insights from both academic and community settings to reveal how care is really delivered. And in a fast-evolving treatment landscape, those insights aren’t just helpful—they’re essential.
Treating the disease is only part of the job—we’re here to support the whole journey.
Learn more about PRECISION here.
3) We’re empowering providers to advance care in new way
True care goes beyond numbers. It’s about the person behind the diagnosis and the life lived between treatments. Each member of a patient’s care team plays a unique role helping to fill the gaps that data can’t capture: the emotional toll, the daily struggles, the unseen realities of living with cancer. We know how important it is to work directly with providers, researchers, and professional groups to ensure every part of a patient’s journey is supported beyond the clinic door.
Novartis supports healthcare providers in our shared pursuit of better outcomes for patients by providing tools, resources and programs that help providers improve care, build trust with patients, and advance the future of prostate cancer:
Visit our healthcare provider site for more resources and learn how to submit research proposals.
Together, we’re driving innovative solutions—fueled by a robust pipeline of promising new treatments options, ongoing clinical trials, real-world insights, and bold research. All of this is in an effort to inform more personalized treatment strategies, advancing what cancer care can be. This is how we continue reimagining medicine, together—not someday, but every day.
